NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/24/2024
Back to search
Official data from USPTO
MOFFITT CANCER CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MOFFITT CANCER CENTER
ST13
US500000086214921Class
16, 41, 42, 44
Filing
86214921
Registration
4640131
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/24/2024
Trademark type
Word
Nice classes
16, 41, 42, 44
Filing date
03/07/2014
Registration date
11/18/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/24/2024
Last transaction
04/24/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/30/2007
First use in commerce
11/30/2007
Drawing code
4
Owner type
03
Owner location
Tampa, FL, US
Examiner
KERTGATE, AMY L
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Representatives
Corey K. Cho SALIWANCHIK, LLOYD & EISENSCHENK, P.A.
Technical classification
Nice Classes
Class 16Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Publicationsprinted instructional and teaching materialsbrochurespamphletsbulletinsnewsletters and magazinesall in the field of health carecancer protectionpreventiondetection and treatmentmedical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases
Class 41
Medical educational servicesconducting lecturesseminars and workshops to health care practitionerspatients and patient caregivers in the field of health carecancer care and prevention of cancermedical diagnosticsprognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases
Class 42
Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicianspatients and researchersan online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseasesproviding data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseasesproviding evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesmatching particular patients to a particular drugtreatmenttherapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesproviding objective data in usable form on the effectiveness of a drug or diagnostic test
Class 44
Providing health caremedical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness; medical servicescancer care and prevention of cancermedical diagnosticsprognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counselingoffering advice regarding cancer preventiondetectiontreatment and clinical testing in the field of cancer and other diseases
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/24/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/24/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/22/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/18/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/28/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/28/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2020
E815
TEAS SECTION 8 & 15 RECEIVED
01/31/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/18/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/18/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/02/2014
PUBO
PUBLISHED FOR OPPOSITION
09/02/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/13/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/26/2014
ALIE
ASSIGNED TO LIE
07/26/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/15/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/21/2014
GNRT
NON-FINAL ACTION E-MAILED
06/21/2014
CNRT
NON-FINAL ACTION WRITTEN
06/21/2014
DOCK
ASSIGNED TO EXAMINER
06/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2014
NWAP
NEW APPLICATION ENTERED
03/11/2014
Continuous trademark protection
Get notified about every new filing that threatens MOFFITT CANCER CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.